Differential cognitive deterioration in dementia: A two year longitudinal study

Journal of Alzheimer's Disease

Volumn 24, Issue 1, 2011, Pages 125-136

  Chamberlain, Samuel R ^a,b,c   Blackwell, Andrew D ^a,b   Nathan, Pradeep J ^a,b,c   Hammond, Geoff ^a   Robbins, Trevor W ^a,b   Hodges, John R ^d   Michael, Albert ^a   Semple, James M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Alzheimer's disease; cognition; dementia; enrichment; longitudinal; prediction; semantic

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE COURSE; FEMALE; FOLLOW UP; GROWTH CURVE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SUBJECTIVE MEMORY IMPAIRMENT;

EID: 79955653242     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100450     Document Type: Article

References (38)

1. Brookmeyer R, Johnsona E, Ziegler-Grahamb K, Arrighic HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191. (Pubitemid 46825511)
2. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29, 125-132. (Pubitemid 350191430)
3. WHO (2003) World Heath Report: Shaping the Future, WHO, Geneva.
4. Comas-Herrera A, Wittenberg R, Pickard I, Knapp M (2005) Cognitive impairment in older people: its implications for future demand for services and costs. PSSRU Discussion Paper, 1728.
5. Comas-Herrera A, Wittenberg R, Pickard L, Knapp M (2007) Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 22, 1037-1045. (Pubitemid 47616781)
6. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neuro l9, 1118-1127.
7. Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2, 566-580. (Pubitemid 37361748)
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's dis-ease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
9. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visu-ospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111(Pt 3), 695-718.
10. Sahakian BJ, Downes JJ, Eagger S, Evenden JL, Levy R, Philpot MP, Roberts AC, Robbins TW (1990) Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type. Neuropsy-chologia28, 1197-1213.
11. Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD, Iddon JL, Robbins TW, Sahakian BJ (2001) Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geri-atr Cogn Disord 12, 265-280. (Pubitemid 32429726)
12. Sahgal A, Galloway PH, McKeith IG, Lloyd S, Cook JH, Ferrier IN, Edwardson JA (1992) Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol 49, 1043-1046.
13. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahy-droaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psy-chopharmacology (Berl) 110, 395-401. (Pubitemid 23074561)
14. Chamberlain SR, Sahakian BJ (2006) The neuropsychology of mood disorders. Curr Psychiatry Rep 8, 458-463. (Pubitemid 46017235)
15. Sheline YI, Gado MH, Kraemer HC (2003) Untreated depres-sion and hippocampal volume loss. Am J Psychiatry 160, 1516-1518. (Pubitemid 41070930)
16. Steffens DC (2008) Separating mood disturbance from mild cognitive impairment in geriatric depression. Int Rev Psychi-atry 20, 374-381.
17. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical char-acterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
18. Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR (2004) Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 17, 42-48. (Pubitemid 37499966)
19. Nelson HE (1982) National Adult Reading Test (NART): Test Manual, NFER-Nelson, Windsor.
20. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: apreliminary report. J Psychiatr Res 17, 37-49. (Pubitemid 13123113)
21. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients forthe clinician. J Psychiatr Res 12, 189-198.
22. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1364.
23. Weschler D (1987) Weschler Memory Scale-Revised, Psychological Corporation, San Antonio.
24. Baddeley A, Emslie H, Nimmo-Smith I (1994) Doors and People, Thames Valley Test Company, Bury St Edmunds.
25. McKenna P, Warrington EK (1983) Graded Naming Test, NFER Nelson, Windsor.
26. Bozeat S, Lambon Ralph MA, Patterson K, Garrard P, Hodges JR (2000) Non-verbal semantic impairment in semantic dementia. Neuropsychologia 38, 1207-1215. (Pubitemid 30345515)
27. Warrington EK (1996) Cambden Memory Tests, Psychology Press, Hove.
28. Newcombe F (1969) Missile Wounds ofthe Brain, Oxford University Press, London.
29. Hodges JR, Patterson K (1995) Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia 33, 441-459.
30. Hodges JR, Erzinclioglu S, Patterson K (2006) Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very-long-term follow-up study. Dement Geriatr Cogn Disord 21, 380-391. (Pubitemid 43735683)
31. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimertype. Br JPsychiatry 154, 797-800. (Pubitemid 19172212)
32. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1989) Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia27, 1329-1343. (Pubitemid 20015615)
33. Owen AM, Sahakian BJ, Hodges JR, Summers BA, Polkey CE, Robbins T (1995) Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 9, 126-140.
34. Cattell RB (1978) The Scientific Use of Factor Analysis, Plenum, New York.
35. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ (2002) Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc 8, 58-71. (Pubitemid 34130474)
36. Jacova C, Hsiung GY, Feldman HH (2006) Dropouts and refusals in observational studies: lessons for prevention trials. Neurology 67, S17-S20. (Pubitemid 44684673)
37. Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Andrieu S, Grand A, Vellas B (2008) Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL. FR study. Neuroepidemiology 31, 69-79.
38. Diniz BS, Pinto JA Jr, Gonzaga ML, Guimaraes FM, Gattaz WF, Forlenza OV (2009) To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 259, 248-256.